SunWay Biotech Co., LTD. reported earnings results for the full year ended December 31, 2023. For the full year, the company reported sales was TWD 571.11 million compared to TWD 425.35 million a year ago. Net income was TWD 44.08 million compared to TWD 30.04 million a year ago.

Basic earnings per share from continuing operations was TWD 1.47 compared to TWD 1.51 a year ago. Diluted earnings per share from continuing operations was TWD 1.47 compared to TWD 1.51 a year ago.